Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -2.19%64 EV-to-EBITDA is 36.33 as of Sep. 14, 2026, which is 7% above its 10-year median of 33.93. GuruFocus rates TSE:3446 with a GF Score™ of 64/100 and a GF Value™ of 円1,801.44 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 516 Medical Devices & Instruments companies, JTEC ranks worse than 83.72% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, JTEC's enterprise value is 円9,394 Mil.
JTEC's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was 円259 Mil. Therefore, JTEC's EV-to-EBITDA for today is 36.33.
The historical rank and industry rank for JTEC's EV-to-EBITDA or its related term are showing as below:
TSE:3446'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -902.95 Med: 33.93 Max: 2866.11
Current: 36.33
During the past 10 years, the highest EV-to-EBITDA of JTEC was 2866.11. The lowest was -902.95. And the median was 33.93.
TSE:3446's EV-to-EBITDA is ranked worse than 83.72% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 13.68
vs TSE:3446: 36.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-09-14), JTEC's stock price is 円1607.00.
JTEC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was 円9.950. Therefore, JTEC's PE Ratio (TTM) for today is 161.51.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
JTEC's share price for today is 円1607.00.
JTEC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円9.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for JTEC's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, JTEC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where JTEC's EV-to-EBITDA falls into.
JTEC's current Enterprise Value is 円9,394 Mil.
JTEC's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円259 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a EV-to-EBITDA of 36.33 as of Sep. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on JTEC. This is near median its historical median of 33.93. According to the industry distribution chart, JTEC ranks #432 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 83.7%.
Is JTEC's EV-to-EBITDA too high?
JTEC's current EV-to-EBITDA of 36.33 is near median its 10-year median of 33.93. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.68. JTEC's value of 36.33 is 165.6% above this industry median. Based on the distribution chart, JTEC ranks #432 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JTEC has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #432 out of 516 companies for EV-to-EBITDA. This places JTEC in the lower half of its industry. The industry median EV-to-EBITDA is 13.68. JTEC's value of 36.33 is 165.6% above this benchmark. While the company's 10-year median is 33.93 vs. the industry median of 13.68, JTEC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.68, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current EV-to-EBITDA of 36.33 is 165.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on JTEC. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current EV-to-EBITDA is 36.33, which is near median its own 10-year median of 33.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,801.44, compared to a current price of 円1,607.00 — trading 10.8% below its estimated fair value. The current EV-to-EBITDA is 36.33, which is near median its 10-year median of 33.93 and 165.6% above the Medical Devices & Instruments industry median of 13.68. JTEC's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For JTEC (TSE:3446), the current EV-to-EBITDA is 36.33 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,607.00 is trading 10.8% below its estimated GF Value™ of 円1,801.44.
GuruFocus considers JTEC to be Modestly Undervalued.
Key valuation signals for TSE:3446:
EV-to-EBITDA: 36.33 (near median its 10-year median of 33.93)
GF Value™: 円1,801.44 vs. price of 円1,607.00 (10.8% below fair value)
Industry Position: 165.6% above the Medical Devices & Instruments median (#432 of 516)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
64GF Score
Get the complete analysis for TSE:3446
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
